TrialDiabetes, obesity & metabolism2018

Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting.

Elizabeth R Seaquist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.